Waters Corporation $WAT Shares Sold by Savant Capital LLC

Savant Capital LLC trimmed its holdings in shares of Waters Corporation (NYSE:WAT) by 25.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,847 shares of the medical instruments supplier’s stock after selling 621 shares during the quarter. Savant Capital LLC’s holdings in Waters were worth $645,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Zions Bancorporation National Association UT purchased a new stake in Waters during the 1st quarter worth about $28,000. IFP Advisors Inc lifted its holdings in shares of Waters by 118.9% during the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock worth $30,000 after purchasing an additional 44 shares during the period. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Waters in the first quarter valued at about $41,000. Creative Financial Designs Inc. ADV raised its stake in shares of Waters by 533.3% during the 2nd quarter. Creative Financial Designs Inc. ADV now owns 190 shares of the medical instruments supplier’s stock worth $66,000 after buying an additional 160 shares in the last quarter. Finally, Steph & Co. acquired a new stake in Waters in the second quarter valued at $73,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on WAT shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Waters in a research note on Wednesday, October 8th. Wall Street Zen cut shares of Waters from a “buy” rating to a “hold” rating in a research note on Saturday, July 26th. JPMorgan Chase & Co. raised their target price on shares of Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a research report on Thursday, October 9th. Wells Fargo & Company boosted their price target on Waters from $315.00 to $385.00 and gave the company an “equal weight” rating in a report on Wednesday, November 5th. Finally, Rothschild & Co Redburn assumed coverage on Waters in a research note on Wednesday, October 8th. They issued a “buy” rating and a $390.00 price target on the stock. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $381.57.

Waters Trading Up 0.1%

Shares of WAT opened at $379.85 on Friday. The company has a market capitalization of $22.61 billion, a P/E ratio of 34.25, a P/E/G ratio of 3.19 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75. Waters Corporation has a one year low of $275.05 and a one year high of $423.56. The stock has a 50-day moving average price of $331.86 and a 200 day moving average price of $327.68.

Waters (NYSE:WAT) last issued its quarterly earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. The business had revenue of $608.55 million for the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%. Sell-side analysts forecast that Waters Corporation will post 12.86 EPS for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.